{
    "root": [
        {
            "id": 0,
            "parent": -1,
            "text": "ROOT",
            "relation": "null"
        },
        {
            "id": 1,
            "parent": 4,
            "text": "Activation of the thrombotic and complement systems is the main recognition and effector mechanisms in the multiple adverse biological responses",
            "relation": "BACKGROUND"
        },
        {
            "id": 2,
            "parent": 1,
            "text": "triggered",
            "relation": "ELABORATION"
        },
        {
            "id": 3,
            "parent": 2,
            "text": "when biomaterials or therapeutic cells come into blood contact . <S>",
            "relation": "CONDITION"
        },
        {
            "id": 4,
            "parent": 0,
            "text": "We have created a surface",
            "relation": "ROOT"
        },
        {
            "id": 5,
            "parent": 4,
            "text": "which is auto - protective to human innate immunity",
            "relation": "ELABORATION"
        },
        {
            "id": 6,
            "parent": 4,
            "text": "by combining three fundamentally different strategies ,",
            "relation": "MANNER-MEANS"
        },
        {
            "id": 7,
            "parent": 6,
            "text": "all developed by us previously ,",
            "relation": "ELABORATION"
        },
        {
            "id": 8,
            "parent": 6,
            "text": "which have been shown to induce substantial , but incomplete hemocompatibility",
            "relation": "ELABORATION"
        },
        {
            "id": 9,
            "parent": 8,
            "text": "when used separately . <S>",
            "relation": "CONDITION"
        },
        {
            "id": 10,
            "parent": 4,
            "text": "In summary , we have conjugated a factor Hebinding peptide ; and an ADP - degrading enzyme ;",
            "relation": "ELABORATION"
        },
        {
            "id": 11,
            "parent": 10,
            "text": "using a PEG linker on both material and cellular surfaces . <S>",
            "relation": "MANNER-MEANS"
        },
        {
            "id": 12,
            "parent": 13,
            "text": "When exposed to human whole blood ,",
            "relation": "TEMPORAL"
        },
        {
            "id": 13,
            "parent": 10,
            "text": "factor H was specifically recruited to the modified surfaces",
            "relation": "ELABORATION"
        },
        {
            "id": 14,
            "parent": 13,
            "text": "and inhibited complement attack . <S>",
            "relation": "ELABORATION"
        },
        {
            "id": 15,
            "parent": 13,
            "text": "In addition , activation of platelets and coagulation was efficiently attenuated ,",
            "relation": "ELABORATION"
        },
        {
            "id": 16,
            "parent": 15,
            "text": "by degrading ADP . <S>",
            "relation": "MANNER-MEANS"
        },
        {
            "id": 17,
            "parent": 10,
            "text": "Thus ,",
            "relation": "ELABORATION"
        },
        {
            "id": 18,
            "parent": 20,
            "text": "by inhibiting thromboinflammation",
            "relation": "MANNER-MEANS"
        },
        {
            "id": 19,
            "parent": 18,
            "text": "using a multicomponent approach ,",
            "relation": "MANNER-MEANS"
        },
        {
            "id": 20,
            "parent": 17,
            "text": "we have created a hybrid surface with the potential",
            "relation": "SAME-UNIT"
        },
        {
            "id": 21,
            "parent": 20,
            "text": "to greatly reduce incompatibility reactions",
            "relation": "ENABLEMENT"
        },
        {
            "id": 22,
            "parent": 21,
            "text": "involving biomaterials and transplantation . <S> <P>",
            "relation": "ELABORATION"
        }
    ]
}